High-dose methotrexate: A clinical and pharmacokinetic evaluation
- 1 December 1982
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 9 (3) , 156-160
- https://doi.org/10.1007/bf00257744
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The role of 7-hydroxymethotrexate during methotrexate anti-cancer therapyCancer Letters, 1980
- High-dose methotrexate: Preliminary evaluation of a pharmacokinetic approachCancer Chemotherapy and Pharmacology, 1979
- Evaluation of 24-hour infusion of high-dose methotrexate ?Pharmacokinetics and toxicityCancer Chemotherapy and Pharmacology, 1979
- Pharmacokinetic monitoring of high-dose methotrexateCancer Chemotherapy and Pharmacology, 1979
- Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate ToxicityNew England Journal of Medicine, 1977
- Role of drug concentration, duration of exposure, and endogenous metabolites in determining methotrexate cytotoxicity.1977
- Eine mikromethode 7air kreatininbestimmungClinica Chimica Acta; International Journal of Clinical Chemistry, 1971
- TECHNIQUES FOR STUDY OF RESISTANCE TO FOLIC ACID ANTAGONISTS.1964